Study of Natural Cytotoxicity Receptors in Patients with HIV/AIDS and Cancer: A Cross-Sectional Study

Table 2

Treatment regimen in HIV/AIDS group and HIV/AIDSWC group.

Treatment regimen	Number of patients of the HIV/AIDS group	Number of patients of the HIV/AIDSWC group
NRTI + NNRTI + PI + FI	—	1
NRTI + NNRTI + PI	1	3
NRTI + NNRTI + II	2	—
NRTI + NNRTI	14	11
NRTI + PI	7	4
NRTI	1	2

NRTI: nucleoside/nucleotide reverse transcriptase inhibitors; NNRTI: non-nucleoside reverse transcriptase inhibitors; PI: protease inhibitor; FI: fusion inhibitors; II: integrase inhibitors.